Clinical Trial Update: A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

View source ↗

Summary

A 5-year longitudinal observational study is being conducted on patients receiving therapy for inflammatory bowel disease. The trial is sponsored by Target Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Indeterminate Colitis
• Ulcerative Colitis

Snippet

Sponsor: Target PharmaSolutions, Inc. | Conditions: Inflammatory Bowel Diseases, Crohn's Disease | Status: ACTIVE_NOT_RECRUITING